Trial Profile
Phase 1 Dose Escalation Study With Sorafenib in Combination With Sirolimus in Patients With Solid Tumor.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Sirolimus
- Indications Solid tumours
- Focus Adverse reactions
- 23 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Aug 2007 New trial record.